← Back to Search

Antiretroviral Agent

The Visceral Adiposity Measurement and Observation Study (VAMOS Trial)

N/A
Waitlist Available
Led By Jordan Lake, MD
Research Sponsored by Theratechnologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

The Visceral Adiposity Measurement and Observation Study

Eligible Conditions
  • Fatty Liver
  • Liver scarring
  • Liver Disease
  • Nonalcoholic fatty liver disease
  • Fatty Liver Disease
  • HIV/AIDS
  • HIV
  • HIV Infection
  • Lipohypertrophy
  • Non-alcoholic Fatty Liver Disease
  • Liver Fibrosis
  • Waist Measurement
  • Body Mass Index
  • HIV Lipodystrophy Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Iliac waist circumference measurement (in cm).
Umbilical waist circumference measurement (in cm).
Visceral Adiposity Measurement by CT surface area (cm2).
Secondary study objectives
Fibroscan Controlled Attenuation Parameter (CAP) in decibels/minute
Fibroscan Vibration Controlled Transient Elastography (VCTE) in kPa
Framingham Cardiovascular Risk strata (low, intermediate or high)
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Study ParticipantsExperimental Treatment2 Interventions
Waist and hip circumferences, CT Scan and FibroScan and Quality of Life questionnaire, vital signs, urine and blood testing in Adults with HIV on continuous Anti-Retroviral Therapy treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diagnostic Test
2022
N/A
~2120
HIV Anti-retroviral Background Therapy
2022
N/A
~200

Find a Location

Who is running the clinical trial?

Norwich Clinical Research Associates Ltd.OTHER
4 Previous Clinical Trials
596 Total Patients Enrolled
TheratechnologiesLead Sponsor
10 Previous Clinical Trials
2,082 Total Patients Enrolled
Medpace, Inc.Industry Sponsor
96 Previous Clinical Trials
29,681 Total Patients Enrolled
Vanderbilt University Medical CenterOTHER
908 Previous Clinical Trials
934,644 Total Patients Enrolled
EchosensIndustry Sponsor
16 Previous Clinical Trials
14,403 Total Patients Enrolled
Dacima ConsultingOTHER
19 Previous Clinical Trials
87,779 Total Patients Enrolled
Jordan Lake, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
John Koethe, MDPrincipal InvestigatorVanderbilt University Medical Center
3 Previous Clinical Trials
278 Total Patients Enrolled
Jeffery Carr, DRPrincipal InvestigatorVanderbilt University Medical Center
~53 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top